De La Salle University is collaborating on a market study for healthcare fraud analytics. The university, known for its research productivity and academic excellence, is partnering with Verified Market Research. **Positive Factors:**…
Category: Health
Fennec Pharmaceuticals: Equity Offering and European Licensing Deal
Fennec Pharmaceuticals has announced the pricing of its common shares offering, alongside updates on its strategic licensing agreement with Norgine Pharmaceuticals Ltd. for PEDMARQSI® in Europe. **Positive Factors:** * **Capital Infusion:** The…
Fennec Pharmaceuticals: Strategic Licensing and Private Offering Updates
Fennec Pharmaceuticals has announced a private offering of common shares, following a strategic move in March 2024 where they entered an exclusive licensing agreement with Norgine Pharmaceuticals Ltd. This agreement allows Norgine…
CorMedix Inc. Reports Strong Q3 2025 Financials, Raises Guidance
CorMedix Inc. reported robust Q3 2025 financial results, with significant net revenue and net income, and has raised its FY 2025 guidance. These strong financial metrics and positive outlook are highly positive…
XOMA Royalty Reports Q3 2025 Results and Business Achievements
XOMA Royalty has reported its Q3 2025 financial results and highlighted key business achievements, including securing royalty interests in early-stage assets through an acquisition. This strategy focuses on generating revenue from royalty…
Abeona Therapeutics Reports Q3 2025 Results and Updates Guidance
Abeona Therapeutics has reported its Q3 2025 financial results and provided corporate updates, including a shift in patient treatment timelines for ZEVASKYN®. While the delay is a negative factor, the company notes…
PolyPid Provides Corporate Update and Q3 2025 Financials, Eyeing NDA Submission
PolyPid has provided a corporate update and its Q3 2025 financial results, highlighting progress towards a Pre-NDA meeting with the FDA for its D-PLEX product and an anticipated NDA submission in early…
India’s Pharma Sector: A Growing Opportunity for PCD Companies
The Indian pharmaceutical sector is experiencing rapid growth, driven by increasing healthcare awareness and demand for medicines. This presents a significant positive opportunity for Pharmaceutical Distribution and Consulting (PCD) companies like Jes…
Novo Nordisk Fights to Keep Medicaid Paying for Weight-Loss Drugs
Novo Nordisk is actively lobbying to maintain Medicaid coverage for its weight-loss drug Wegovy, facing resistance from some U.S. states concerned about costs. This situation highlights the ongoing debate about the affordability…
US Tariffs on Indian Pharma: A Bitter Pill for the Sector
The prospective imposition of tariffs on pharmaceutical imports by the Trump administration poses a significant challenge for the Indian pharmaceutical sector. Tariffs can increase the cost of imported goods, impacting profitability and…